Reversair ODT 5 mg (Dispersible Tablet)
Unit Price: ৳ 9.00 (3 x 10: ৳ 270.00)
Strip Price: ৳ 90.00
Medicine Details
Category | Details |
---|---|
Generic | Montelukast sodium |
Company | Aci limited |
Also available as |
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
- Selective and orally active leukotriene receptor antagonist
- Inhibits the cysteinyl leukotriene receptor (CysLT1)
- Correlated with the pathophysiology of asthma & allergic rhinitis
- Contributes to the signs and symptoms of asthma
Dosage & Administration
- Dosage for adults and adolescents 15 years of age and older: Montelukast 10 mg tablet once daily
- Dosage for pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily
- Dosage for pediatric patients 2 years to 5 years of age: Montelukast 4 mg tablet once daily
- Dosage for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily
Interaction
- No clinically important effects on the pharmacokinetics of certain drugs
- May be used concomitantly with a wide range of commonly prescribed drugs
- Phenobarbital decreased the AUC of Reversair ODT by approximately 40%
Contraindications
- Hypersensitivity to any component of this product
Side Effects
- Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
- Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders
- Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor
Pregnancy & Lactation
- Crosses the placenta following oral dosing in rats and rabbits
- Should be used during pregnancy only if clearly needed
- Caution should be exercised when given to a nursing mother
Precautions & Warnings
- Not indicated for use in the reversal of bronchospasm in acute asthma attacks
- Patients should have appropriate rescue medication available
- Should not be used as monotherapy for the treatment and management of exercise induced bronchospasm
- Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Reversair ODT
Overdose Effects
- No adverse experiences in the majority of reports
- Most frequently occurring adverse experiences include abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity
Therapeutic Class
Leukotriene receptor antagonists
Storage Conditions
Store in cool & dry place below 30°C, protect from light & moisture
Chemical Structure
- Molecular Formula: C35H36ClNO3S
- Chemical Structure Image: Montelukast Sodium Chemical Structure
Common Questions about Reversair ODT 5 mg Tablet
- What is Reversair ODT 5 mg DT?
- What is Reversair ODT 5 mg DT used for?
- How soon can the effect of Reversair ODT 5 mg DT be observed?
- How long does the effect of Reversair ODT 5 mg DT last?
- Should I use Reversair ODT 5 mg DT empty stomach?
- What if I miss a dose of Reversair ODT 5 mg DT?
- Are there any pregnancy warnings for Reversair ODT 5 mg DT?
- General Instructions
Related Brands
- Aeron FT 4 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron FT 5 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron 10 mg (Tablet) - healthcare-pharmaceuticals-ltd
- Montinex 4 mg (Chewable Tablet) - beacon-pharmaceuticals-plc
- Montinex 5 mg (Chewable Tablet) - beacon-pharmaceuticals-plc